Shares of Cantel Medical Corp. (NYSE:CMD) have been assigned an average broker rating score of 2.50 (Hold) from the four analysts that cover the company, Zacks Investment Research reports. Three investment analysts have rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.
Analysts have set a 1-year consensus target price of $120.00 for the company and are expecting that the company will post $0.55 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Cantel Medical an industry rank of 105 out of 256 based on the ratings given to its competitors.
Separately, Raymond James downgraded shares of Cantel Medical from an “outperform” rating to a “market perform” rating in a report on Friday, March 1st.
Cantel Medical (NYSE:CMD) last posted its quarterly earnings data on Thursday, February 28th. The company reported $0.57 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.05). Cantel Medical had a return on equity of 16.18% and a net margin of 8.22%. The company had revenue of $224.54 million for the quarter, compared to the consensus estimate of $227.90 million. On average, equities analysts expect that Cantel Medical will post 2.36 EPS for the current year.
About Cantel Medical
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.
Further Reading: How to track put option volume
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.